Manipal Health Enterprises IPO Day 1: Subscription Status, Key Issue Details and IPO Timeline

Manipal Health Enterprises Limited opened its Initial Public Offering (IPO) for subscription on July 29, 2026. The IPO has drawn investor attention as the company is one of India’s leading healthcare providers with an established presence in the multi-speciality hospital segment.

The Manipal Health Enterprises IPO aims to raise ₹9,275.22 crore through a combination of a fresh issue of 13.56 crore equity shares and an Offer for Sale (OFS) of 2.16 crore equity shares. The issue will remain open for subscription until July 31, 2026.

The IPO will close on July 31, 2026. The allotment of shares is expected to be finalised on August 3, 2026, while the company’s shares are scheduled to list on the NSE and BSE on August 5, 2026.

Manipal Health Enterprises IPO Details

• Issue Type: Book Built Issue (Fresh Issue + OFS)
• Total Issue Size: Up to ₹9,275.22 crore
• Fresh Issue: Up to ₹8,000 crore
• Offer for Sale (OFS): Up to ₹1,275.22 crore
• Face Value: ₹2 per equity share
• Price Band: ₹560 to ₹590 per share
• Lot Size: 25 shares
• Minimum Investment Amount (Retail Investor): ₹14,750 (25 shares at the upper price band)
• Listing: BSE, NSE
• Book Running Lead Managers:  Kotak Mahindra Capital Company Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited, UBS Securities India Private Limited and DBS Bank India Private Limited
• Registrar: KFin Technologies Limited

Manipal Health Enterprises IPO Timeline

Note: The allotment and listing dates are tentative and may be revised.

Manipal Health Enterprises IPO Day 1 Subscription Status

[July 29, 2026, 10:10 AM]

Objective of Manipal Health Enterprises IPO Proceeds

The company plans to utilise the proceeds from the fresh issue to support its business objectives and strengthen its financial position.

The key objectives of the IPO proceeds include:

• Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of its material subsidiaries, namely, Manipal Hospitals Private Limited
•  Acquisition of minority stake in its stepdown Subsidiary, Sahyadri Hospitals Private Limited
• General corporate purposes.

About Manipal Health Enterprises Limited

Manipal Health Enterprises is one of India's leading multispecialty hospital chains, operating a nationwide network of 49 hospitals with 13,037 licensed beds across 14 states and union territories as of March 31, 2026. The company is the country's largest private hospital network by bed capacity and the second largest by the number of hospitals. During Fiscal 2026, it provided healthcare services to 7.63 million patients and had a network of 11,064 doctors.

The company primarily focuses on tertiary and quaternary healthcare services. Its key specialties—cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences (CONGO-R)—accounted for 64.3% of its gross inpatient revenue in Fiscal 2026. Manipal Health has also strengthened its presence through acquisitions such as AMRI Hospitals, Medica Synergie, and the Sahyadri Group, and aims to increase its capacity by adding around 2,426 licensed beds by 2030.

Manipal Health Enterprises IPO: Industry Peer Comparison

According to the company’s RHP, the listed peers of Manipal Health Enterprises include Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, and Max Healthcare Institute Limited. The companies operate in the multi-specialty hospital segment and are compared on key financial and operational parameters.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.  

To read the RA disclaimer, please click here